Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05095350Phase 1Completed
Phase 1, randomised, double-blind trial in hypertension (HTN) and prehypertension (2 arms), sponsored by Chinese Academy of Medical Sciences. Primary endpoint: Change in Office Systolic Blood Pressure at Day 56. Started Dec 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05095350.